Literature DB >> 32887583

Disparities in end-of-life care, expenditures, and place of death by health insurance among cancer patients in China: a population-based, retrospective study.

Zhong Li1,2, Peiyin Hung2, Ruibo He3, Xiaoming Tu4, Xiaoming Li5, Chengzhong Xu6, Fangfang Lu6, Pei Zhang6, Liang Zhang7,8.   

Abstract

BACKGROUND: Disparities in the utilization, expenditures, and quality of care by insurance types have been well documented. Such comparisons have yet to be investigated in end-of-life (EOL) settings in China, where public insurance covers over 95% of the Chinese population. This study examined the associations between health insurance and EOL care in the last six months of life: outpatient visits, emergency department (ED) visits, inpatient services, intensive care unit (ICU) admissions, expenditures, and place of death among the cancer patients.
METHODS: A total of 398 patients diagnosed with cancer who survived more than 6 months after diagnosis and died from July 2015 to June 2017 in urban Yichang, China, were included. Descriptive analysis and multivariate regression models were used to investigate the bivariate and independent associations, respectively, between health insurance with EOL healthcare utilization, expenditures and place of death.
RESULTS: Urban Employee Basic Medical Insurance (UEBMI) beneficiaries visited EDs more frequently than Urban Resident-based Basic Medical Insurance (URBMI) and New Rural Cooperative Medical Scheme (NRCMS) beneficiaries (marginal effects [95% Confidence Interval]: 2.15 [1.81-2.48] and 1.92 [1.59-2.26], respectively). NRCMS and UEBMI beneficiaries had more hospitalizations than URBMI beneficiaries (1.01 [0.38-1.64] and 0.71 [0.20-1.22], respectively). Compared to URBMI beneficiaries, NRCMS beneficiaries and UEBMI beneficiaries had ¥15,722 and ¥43,241 higher expenditures. Similarly, UEBMI beneficiaries were most likely to die in hospitals, followed by NRCMS (UEBMI vs. NRCMS: 0.23 [0.11-0.36]) and URBMI (UEBMI vs. URBMI: 0.67 [0.57-0.78]) beneficiaries.
CONCLUSIONS: The disproportionately lower utilization of EOL care among NRCMS and URBMI beneficiaries, compared to UEBMI beneficiaries, raised concerns regarding quality of EOL care and financial burdens of NRCMS and URBMI beneficiaries. Purposive hospice care intervention might be warranted to address EOL care for these beneficiaries in China.

Entities:  

Keywords:  Cancer patients; End-of-life care; Expenditures; Health insurance; Place of death

Mesh:

Year:  2020        PMID: 32887583      PMCID: PMC7650520          DOI: 10.1186/s12889-020-09463-1

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  33 in total

1.  Factors important to patients' quality of life at the end of life.

Authors:  Baohui Zhang; Matthew E Nilsson; Holly G Prigerson
Journal:  Arch Intern Med       Date:  2012-08-13

Review 2.  Consolidating the social health insurance schemes in China: towards an equitable and efficient health system.

Authors:  Qingyue Meng; Hai Fang; Xiaoyun Liu; Beibei Yuan; Jin Xu
Journal:  Lancet       Date:  2015-10-10       Impact factor: 79.321

3.  Reducing costs at the end of life through provider incentives for hospice care: A retrospective cohort study.

Authors:  Bradley Chen; Chin-Chi Kuo; Nicole Huang; Victoria Y Fan
Journal:  Palliat Med       Date:  2018-05-25       Impact factor: 4.762

4.  The impacts of health insurance on health care utilization among the older people in China.

Authors:  Xin Li; Wei Zhang
Journal:  Soc Sci Med       Date:  2013-03-05       Impact factor: 4.634

5.  Advance Care Planning in Chinese Seniors: Cultural Perspectives.

Authors:  Hon Wai Benjamin Cheng
Journal:  J Palliat Care       Date:  2018-03-23       Impact factor: 2.250

6.  End-of-life care for lung cancer patients in the United States and Ontario.

Authors:  Joan L Warren; Lisa Barbera; Karen E Bremner; K Robin Yabroff; Jeffrey S Hoch; Michael J Barrett; Jin Luo; Murray D Krahn
Journal:  J Natl Cancer Inst       Date:  2011-05-18       Impact factor: 13.506

7.  Health insurance status and the care of nursing home residents with advanced dementia.

Authors:  Keith S Goldfeld; David C Grabowski; Daryl J Caudry; Susan L Mitchell
Journal:  JAMA Intern Med       Date:  2013 Dec 9-23       Impact factor: 21.873

8.  Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China.

Authors:  Xuejun Yin; Yue Xu; Xiaowei Man; Liming Liu; Yan Jiang; Liying Zhao; Wei Cheng
Journal:  Cancer Med       Date:  2019-05-07       Impact factor: 4.452

9.  End-of-life cost and its determinants for cancer patients in urban China: a population-based retrospective study.

Authors:  Zhong Li; Zijing Pan; Liang Zhang; Ruibo He; Shan Jiang; Chengzhong Xu; Fangfang Lu; Pei Zhang; Boyang Li
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

10.  Effect of integrated urban and rural residents medical insurance on the utilisation of medical services by residents in China: a propensity score matching with difference-in-differences regression approach.

Authors:  Dai Su; Ying-Chun Chen; Hong-Xia Gao; Hao-Miao Li; Jing-Jing Chang; Di Jiang; Xiao-Mei Hu; Shi-Han Lei; Min Tan; Zhi-Fang Chen
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

View more
  3 in total

1.  Disparities in end-of-life care, expenditures, and place of death by health insurance among cancer patients in China: a population-based, retrospective study.

Authors:  Zhong Li; Peiyin Hung; Ruibo He; Xiaoming Tu; Xiaoming Li; Chengzhong Xu; Fangfang Lu; Pei Zhang; Liang Zhang
Journal:  BMC Public Health       Date:  2020-09-04       Impact factor: 3.295

2.  Place of death and phenomenon of going home to die in Chinese adults: A prospective cohort study.

Authors:  Li Weng; Yizhen Hu; Zhijia Sun; Canqing Yu; Yu Guo; Pei Pei; Ling Yang; Yiping Chen; Huaidong Du; Yuanjie Pang; Yan Lu; Junshi Chen; Zhengming Chen; Bin Du; Jun Lv; Liming Li
Journal:  Lancet Reg Health West Pac       Date:  2021-11-09

3.  Socioeconomic inequality in health care use among cancer patients in China: Evidence from the China health and retirement longitudinal study.

Authors:  Huiru Zhang; Yu Fu; Mingsheng Chen; Lei Si
Journal:  Front Public Health       Date:  2022-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.